Jennifer Jin has over fifteen years of accounting and finance experience with ten years focused in the biotech industry. Jennifer brings to Veralox experience in corporate financial leadership, accounting, budget development, financial risk management, IPO readiness and follow-on offering. Jennifer completed an IPO in GlycoMimetics and an acquisition of Imago BioSciences in her career.

Jennifer received her M. S. in Accounting from Indiana University Kelley School of Business and M.A. in English Language and Literature from Jilin University in China. Jennifer is an active CPA in the states of Maryland and Indiana.

• 

  Controller in Veralox Therapeutics

  Developing new therapies for life-threatening immuno-inflammatory diseases